API OMR GLOBAL

Isosorbide Mononitrate Market

  • Home
  • »
  • Isosorbide Mononitrate Market

Isosorbide Mononitrate Market Size, Share & Industry Analysis, By Application (Angina Pectoris, Heart Failure, Hypertension), By End-User (Hospitals, Clinics, Home Care Settings), By Formulation (Tablets, Extended-Release Tablets, Oral Solution), Forecast 2025–2035

The Isosorbide Mononitrate market is projected to grow at a CAGR of 5.0% from 2025 to 2035. Isosorbide Mononitrate is a nitrate vasodilator commonly used to prevent and treat angina pectoris (chest pain) and to manage heart failure and hypertension. The increasing prevalence of cardiovascular diseases, particularly coronary artery disease (CAD) and chronic heart failure, is a major driver for the market. The growing elderly population, which is more susceptible to cardiovascular conditions, coupled with the shift toward preventive healthcare and long-term therapies, further contributes to the demand for Isosorbide Mononitrate. The availability of various formulations, including extended-release tablets and oral solutions, offers flexibility for patient treatment regimens, promoting better patient adherence.

Geographically, North America holds the largest share of the Isosorbide Mononitrate market, driven by high cardiovascular disease prevalence and advanced healthcare infrastructure, especially in the U.S. and Canada. Europe follows closely, with countries like Germany, France, and the UK having a strong demand for Isosorbide Mononitrate, fueled by aging populations and the widespread use of nitrate vasodilators for heart-related conditions. Asia-Pacific is expected to witness significant growth due to improvements in healthcare access, rising cardiovascular disease incidences, and increased healthcare spending in countries like China and India. Latin America and the Middle East are also emerging markets, driven by increasing healthcare awareness and the expansion of heart disease management programs.

The Isosorbide Mononitrate market is expected to witness steady growth, driven by the increasing global burden of cardiovascular diseases. The availability of multiple formulations to cater to different patient needs, along with rising demand for preventive healthcare, will continue to support market expansion. Manufacturers focusing on formulation innovation, patient adherence, and clinical efficacy will likely have a competitive advantage in this growing market.

Seeking Comprehensive Intelligence on Different markets? Get in Touch with our Experts

Report Scope & Segmentation

  1. Introduction
  • Overview of Isosorbide Mononitrate
  • Key Applications & Industry Use Cases
  • Market Scope & Study Objectives
  1. Market Overview
  • Global Market Size & Growth Trends (Historical & Forecast)
  • Market Value & Revenue Analysis
  • Demand-Supply Dynamics
  1. Segmental Outlook
  • By Application
    • Angina Pectoris
    • Heart Failure
    • Hypertension
  • By End-User
    • Hospitals
    • Clinics
    • Home Care Settings
  • By Formulation
    • Tablets
    • Extended-Release Tablets
    • Oral Solution
  1. Price Analysis
  • Current Price Trends (Per kg & Per Ton)
  • Price Fluctuation Factors (Raw Material Costs, Production, Trade Tariffs)
  • Regional Price Comparison (North America, Europe, Asia-Pacific, and Other)
  1. Production & Supply Volume
  • Global Production Capacity & Key Manufacturers
  • Production Process & Technological Developments
  • Raw Material Analysis
  1. Trade Analysis (Import & Export)
  • Major Exporting & Importing Countries
  • Trade Volume & Value Statistics
  • Impact of Trade Regulations & Policies
  1. Regional Analysis
  • North America (US and Canada)
  • Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, Taiwan, India, and Rest of Asia-Pacific)
  • Rest of the World (Latin America, Middle East, and Africa)
  1. Competitive Landscape
  • Top Global Manufacturers & Market Share
  • Company Profiles & Key Developments
  • Mergers, Acquisitions & Investments
  1. Regulatory & Compliance Factors
  • FDA, REACH, and Other Regulatory Frameworks
  • Environmental & Safety Considerations
  • Emerging Policies Impacting Market Growth
  1. Conclusion & Strategic Recommendations
  • Key Takeaways for Stakeholders
  • Market Entry Strategies
What is Isosorbide Mononitrate?
Isosorbide Mononitrate is a medication primarily used to prevent angina (chest pain) associated with coronary artery disease. It works by dilating blood vessels, thereby reducing the heart's workload and improving blood flow to the heart.
What is the market growth of Isosorbide Mononitrate?
The Isosorbide Mononitrate market is expected to grow at a CAGR of 5.0% from 2025 to 2035. This growth is driven by the increasing incidence of cardiovascular diseases, particularly angina and heart failure, as well as the rising adoption of isosorbide mononitrate as a treatment for these conditions.
What are the drivers of the Isosorbide Mononitrate market?
Key drivers for the Isosorbide Mononitrate market include the rising prevalence of cardiovascular diseases, increasing awareness about heart health, and advancements in healthcare infrastructure that allow for better diagnosis and treatment of heart-related conditions. The growing geriatric population and the demand for effective long-term management of angina also contribute to market growth.
Who are the key players operating in the Isosorbide Mononitrate market?
Prominent players in the Isosorbide Mononitrate market include companies like Teva Pharmaceuticals, Mylan, and Cadila Healthcare. These companies manufacture and distribute Isosorbide Mononitrate in various formulations for the treatment of angina and heart failure.
Which region would exhibit the fastest growth in the Isosorbide Mononitrate market?
The Asia-Pacific region is expected to exhibit the fastest growth in the Isosorbide Mononitrate market during 2025–2035. This growth can be attributed to the rising incidence of cardiovascular diseases, expanding healthcare infrastructure, and the increasing adoption of effective treatments in countries like China, India, and Japan.
$2500/- Single User License
$4000/- Multi User License
$5500/- Corporate License

How can we help you?

Reach out to discuss how our team can help your business achieve real results.